|
Uzbekistan
|
D014610 |
[A country in Central Asia, north of Turkmenistan, south of Kazakhstan. The capital is Tashkent.
] |
|
V(D)J Recombination
|
D060152 |
[The process by which the V (variable), D (diversity), and J (joining) segments of IMMUNOGLOBULIN GENES or T-CELL RECEPTOR GENES are assembled during the development of LYMPHOID CELLS using NONHOMOLOGOUS DNA END-JOINING.
] |
|
V-Set Domain-Containing T-Cell Activation Inhibitor 1
|
D060907 |
[A B7 antigen subtype that inhibits the costimulation of T-cell activation, proliferation, cytokine production and development of cytotoxicity. The over expression of this protein in a variety of tumor cell types suggests its role in TUMOR IMMUNE EVASION.
] |
|
VDJ Exons
|
D050441 |
[Exons that are created in vivo during LYMPHOCYTE maturation from the V, D, and J gene segments of immunoglobulin superfamily genes (e.g., the IMMUNOGLOBULIN HEAVY CHAIN GENES, or the T-CELL RECEPTOR BETA GENES or T-CELL RECEPTOR GAMMA GENES ) by the VDJ RECOMBINASE system.
] |
|
VDJ Recombinases
|
D045567 |
[Recombinases involved in the rearrangement of immunity-related GENES such as IMMUNOGLOBULIN GENES and T-CELL RECEPTOR GENES.
] |
|
Vaccaria
|
D031245 |
[A plant genus of the family CARYOPHYLLACEAE. The common name "Soapwort" is also used with SAPONARIA.
] |
|
Vaccination
|
D014611 |
[Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
] |
|
Vaccination Coverage
|
D000073887 |
[Rate of VACCINATION as defined by GEOGRAPHY and or DEMOGRAPHY.
] |
|
Vaccination Refusal
|
D000072758 |
[Refusal to receive VACCINATION.
] |
|
Vaccine Excipients
|
D000079282 |
[Media added to a vaccine for a specific purpose. These include: preservatives to prevent contamination, adjuvants to stimulate a stronger immune response, and stabilizers. (From https://www.cdc.gov/vaccines pubs/pinkbook/downloads/appendices/b/excipient-table-2.pdf)
] |
|
Vaccine Potency
|
D064166 |
[The relationship between an elicited ADAPTIVE IMMUNE RESPONSE and the dose of the vaccine administered.
] |
|
Vaccine-Preventable Diseases
|
D000079263 |
[Diseases for which vaccines exist that can confer partial or complete protection. (World Health Organization vaccine-safety-training.org)
] |
|
Vaccines
|
D014612 |
[Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
] |
|
Vaccines, Acellular
|
D022282 |
[Vaccines that are produced by using only the antigenic part of the disease causing organism. They often require a "booster" every few years to maintain their effectiveness.
] |
|
Vaccines, Attenuated
|
D014613 |
[Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
] |
|
Vaccines, Combined
|
D017778 |
[Two or more vaccines in a single dosage form.
] |
|
Vaccines, Conjugate
|
D018074 |
[Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
] |
|
Vaccines, Contraceptive
|
D022642 |
[Vaccines or candidate vaccines used to prevent conception.
] |
|
Vaccines, DNA
|
D019444 |
[Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
] |
|
Vaccines, Edible
|
D022462 |
[Vaccines or candidate vaccines derived from edible plants. Transgenic plants (PLANTS, TRANSGENIC) are used as recombinant protein production systems and the edible plant tissue functions as an oral vaccine.
] |
